机械通气新冠患者大型回顾性队列中多重耐药菌定植与感染
该研究回顾性分析意大利米兰Hub医院新冠ICU 2020年10月至2021年5月收治的435例机械通气患者,采用入院时及每周主动筛查的标准化微生物监测。88例(20.2%)入院48小时内分离出多重耐药菌,其余患者中173例(51.2%)诊断多重耐药菌定植、95例(28.1%)多重耐药菌感染、212例(62.7%)非多重耐药菌感染。非多重耐药菌感染早于多重耐药菌感染(6天 vs 10天;p<0.001)。
要点
- 435例机械通气新冠患者中20.2%入院48小时内即分离出多重耐药菌。
- 其余患者中多重耐药菌定植51.2%、多重耐药菌感染28.1%、非多重耐药菌感染62.7%。
- 非多重耐药菌感染出现时间早于多重耐药菌感染(6天 vs 10天;p<0.001)。
核心结论
- 研究结果或可对未来呼吸道病毒大流行起到警示作用,并呼吁加强抗菌药物管理和感染控制措施。
研究设计与样本
- 回顾性评估2020年10月至2021年5月意大利米兰Hub医院新冠ICU收治的所有患者,微生物监测采用入院时及ICU住院期间每周主动筛查的标准化方案。
主要发现
- 435例患者中88例(20.2%)在入院48小时内分离出多重耐药菌。
- 其余患者中,多重耐药菌定植诊断173例(51.2%),多重耐药菌感染95例(28.1%),非多重耐药菌感染212例(62.7%)。
- 非多重耐药菌感染出现时间早于多重耐药菌感染(6天 vs 10天;p<0.001)。
- 多重耐药菌患者ICU内既往抗菌药物暴露比例高于非多重耐药菌患者(116/197 [58.9%] vs 18/140 [12.9%];p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Few data are available on incidence of multidrug-resistant organism (MDRO) colonization and infections in mechanically ventilated patients, particularly during the COVID-19 pandemic. We retrospectively evaluated all patients admitted to the COVID-19 intensive care unit (ICU) of Hub Hospital in Milan, Italy, during October 2020‒May 2021. Microbiologic surveillance was standardized with active screening at admission and weekly during ICU stay. Of 435 patients, 88 (20.2%) had MDROs isolated ≤48 h after admission. Of the remaining patients, MDRO colonization was diagnosed in 173 (51.2%), MDRO infections in 95 (28.1%), and non-MDRO infections in 212 (62.7%). Non-MDRO infections occurred earlier than MDRO infections (6 days vs. 10 days; p<0.001). Previous exposure to antimicrobial drugs within the ICU was higher in MDRO patients than in non-MDRO patients (116/197 [58.9%] vs. 18/140 [12.9%]; p<0.001). Our findings might serve as warnings for future respiratory viral pandemics and call for increased measures of antimicrobial stewardship and infection control.
引用
- Mangioni D, Chatenoud L, Colombo J, et al. Multidrug-Resistant Bacterial Colonization and Infections in Large Retrospective Cohort of Mechanically Ventilated COVID-19 Patients1. Emerg Infect Dis. 2023. PMID: 37486196. doi:10.3201/eid2908.230115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。